Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
intravenous Fe3O4preparation for treatment ofanaemia resulting fromchronic kidney disease .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word ferumoxytol.
Examples
-
The Cambridge, Mass., biopharmaceutical company received a letter from the Food and Drug Administration asking for more information on its iron-replacement drug ferumoxytol.
-
Feraheme® (ferumoxytol) Injection for intravenous (IV) use.
AMAG Pharmaceuticals Provides Business Update - Yahoo! Finance 2011
-
AMAG manufactures and sells Feraheme® ferumoxytol Injection for intravenous use.
AMAG Pharmaceuticals Provides Business Update - Yahoo! Finance 2011
-
Food and Drug Administration to market Feraheme® (ferumoxytol) Injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
-
(NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today jointly announced that the companies have entered into a license, development and commercialization agreement related to Feraheme® (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications.
-
Food and Drug Administration to market Feraheme® (ferumoxytol) Injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
-
(NASDAQ: AMAG - News) will host a conference call and webcast today at 8: 00 am ET to discuss today's announcement that AMAG Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company have entered into a strategic collaboration agreement related to Feraheme® (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications in select ex-US territories.
-
Food and Drug Administration to market Feraheme® (ferumoxytol) Injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
-
(NASDAQ: AMAG) will host a conference call and webcast at 8: 00 am ET to discuss AMAG Pharmaceutical, Inc. and Takeda Pharmaceuticals Company have entered into a strategic collaboration agreement related to Feraheme (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications in select ex-US territories.
American Chronicle American Chronicle 2010
-
(NASDAQ: AMAG) will host a conference call and webcast at 8: 00 am ET to discuss AMAG Pharmaceutical, Inc. and Takeda Pharmaceuticals Company have entered into a strategic collaboration agreement related to Feraheme (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications in select ex-US territories.
American Chronicle American Chronicle 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.